SRI spins off AI-powered drug discovery platform Synfini, Inc.

Synfini to commercialize and scale automated compound testing for rapid drug production

09-Oct-2023 - SRI International announced it is spinning off Synfini, a biosciences platform that accelerates the process by which pharmaceutical and other companies can design, synthesize, and bring to market molecules for drug development. The technology brings together a suite of software and hardware ...

Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Expansion creates nearly 500 new jobs in Glasgow and Stirling

02-Jun-2023 - Merck invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe, efficacious, and meet regulatory requirements. The expansion will create nearly 500 new ...

New organ-on-chip pilot seeks to reduce animal testing in consumer health industry

Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital

08-Mar-2023 - A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software. The pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena ...

NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

25-Mar-2021 - NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets. PharmAI announced a partnership with NanoTemper Technologies, the most innovative producer of biophysical characterization devices. Together, ...

Novel label-free biosensor platform for innovate modern drug screening

lino Biotech closes seed financing round

19-Nov-2020 - After almost a decade of initial invention and joint research on the Focal Molography technology at Roche, a leading player in the diagnostics and pharmaceutical area, and ETH Zurich as one of Europe’s most renowned research institutes, lino Biotech AG has licensed the technology to further ...

Chemists design 'miniecosystems' to test drug function

21-Jun-2018 - Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic. As they report the new method will let researchers save critical time and funding by ...

Link between bacteria metabolism and communication could pave way for new antivirulence drugs

04-Jun-2018 - Researchers have discovered a link between bacteria metabolism and cell-to-cell communication, potentially providing a target for new antivirulence and antibiofilm drugs. Current drugs for bacterial infections aim to kill bacteria in large quantities, but such drugs are often eventually met ...

Faster characterization of organic salts

27-Mar-2018 - UZH researchers have developed a novel method that speeds up the process of determining crystal structures of organic salts and significantly reduces the effort required to do so. As about 40 percent of all active pharmaceutical ingredients are salts, this new crystallographic method is set to ...

Selcia joins Eurofins Group

26-Jan-2018 - Selcia Limited announces that it has been acquired by Eurofins Scientific, a global leader in analytical testing and pharma discovery services. The acquisition of Selcia provides Eurofins with an entry into the custom radiolabelling and innovative pre-clinical, integrated drug discovery services ...

Computer program finds new uses for old drugs

20-Nov-2017 - Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts ...